aTyr Pharma, Inc. Common Stock

ATYRNASDAQ • USD
ThemeBiotech - Drug Development›Rare Disease Therapeutics
0.29 USD
↘ 0.00 (0.77%)🟢PRE MARKET (AS OF 07:39 AM EDT)
🟢Market: OPEN

aTyr Pharma, Inc. Common Stock (ATYR) is currently trading at $0.29. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place ATYR at a fair price relative to peers.

Technical & fundamental data as of Oct 2, 2026.

Open?$0.29
High?$0.29
Low?$0.28
Prev. Close?$0.29
Volume?34.2K
Avg. Volume?5.7M
VWAP?$0.28
Rel. Volume?0.01x
Bid / Ask
Bid?$0.25 × 100
Ask?$0.33 × 100
Spread?$0.09
Midpoint?$0.29
Valuation & Ratios
Market Cap?28.4M
Shares Out?98.1M
Float?97.8M
Float %?99.7%
P/E Ratio?N/A
P/B Ratio?0.58
EPS?-$0.62
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).
Themes
Biotech - Drug Development›Rare Disease Therapeutics
Employees
58
Market Cap
28.2M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.atyrpharma.com
Listed
2015-05-07
Address
10240 SORRENTO VALLEY ROAD
SAN DIEGO, CA 92121
Phone: (858) 731-8389
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
23
Piotroski F-Score?0/9Weak
Altman Z-Score?-13.98Distress
Confidence?54%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?10.91%High
Short Interest?10.7M
Days to Cover?11.9
Free Float97.8M
Avg Daily Volume896.2K
Settlement Date2026-09-15
Financial Health
Current Ratio?5.12Strong
Quick Ratio?5.12Strong
Cash Ratio?1.42Strong
Debt/Equity?0.01Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.58CHEAP▾
P/S?
Peers
100
S&P
3
149.71HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.2CHEAP▾
EV/Sales?
Peers
100
S&P
3
67.58HIGH▾
Returns & Efficiency
ROE?
S&P
3
-124.6%WEAK▾
ROA?
S&P
3
-87.1%WEAK▾
Cash Flow & Enterprise
FCF?$-54819000
Enterprise Value?$12.8M
Fundamentals ratios updated end of day
MarketsMoversWatchlist